对于急性食道水出血,一天对五天的奥克胺输液:一种随机对照试验
Sakkarin Chirapongsathorn1, Arunchai Chang2, Suppakorn Malikhao3
1Division of Gastroenterology and Hepatology, Department of Medicine, Phramongkutklao Hospital and College of Medicine.
The American journal of gastroenterology
|October 15, 2025
概括
一天的奥克特胺输液与5天的输液一样有效,用于防止食道的内镜治疗后再次出血. 这种较短的八丁胺疗法也减少了输血需求和住院时间.
科学领域:
- 胃肠病学 胃肠病学
- 肝病学 肝病学是一种肝病学.
- 临床试验 临床试验
背景情况:
- 食道水出血 (EVB) 是肝硬化的一种严重并发症.
- 对于EVB的内镜后治疗,最佳的八丁注入持续时间尚未得到充分确立.
- 这项研究涉及短期与标准期八丁注射的疗效.
研究的目的:
- 为了比较1天和5天的EVB输液中1天和5天的Octreotide输液的疗效.
- 评估早期 (5天) 和6周的再出血率.
- 评估6周全因死亡率和资源利用情况.
主要方法:
- 全国范围,多中心,非劣势,随机对照试验.
- 220名肝硬化和急性EVB患者正在接受内镜带绑术.
- 1天 (n=109) 与5天 (n=111) 的八胺输液的比较.
主要成果:
- 在早期再出血方面,一天的八丁对5天的八丁没有劣势 (1.80%对1.83%).
- 观察到类似的6周再出血率 (10.81%对比8.26%) 和死亡率 (6.31%对比5.50%).
- 一天组的输血较少,口服饮食时间较短,住院时间较短.
结论:
- 一天的八胺疗法与5天的疗法相比,对于预防EVB后的早期再出血,是不劣的.
- 短期输注八丁胺在预防再次出血和死亡方面表现出相似的有效性.
- 1天的八胺在减少资源利用方面提供了潜在的好处.
相关概念视频
Esophageal Varices-II: Clinical Features and Management
368
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
368
Esophageal Varices-I: Introduction
1.2K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.2K
Esophageal Strictures-II: Clinical Features and Management
428
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
428
Peptic Ulcer Disease IV: Management
430
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
430
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
232
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
232
Bioavailability Study Design: Single Versus Multiple Dose Studies
207
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
207


